Log In
Print this Print this

Aptensio XR, methylphenidate

  Manage Alerts
Collapse Summary General Information
Company Rhodes Pharmaceuticals L.P.
DescriptionExtended realease formulation of methylphenidate
Molecular Target Dopamine transporter
Mechanism of ActionDopamine and norepinephrine reuptake inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationDepression
Indication DetailsTreat attention deficit hyperactive disorder (ADHD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today